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Abstract
Background and Purpose: Thrombus characterization is increasingly considered important in predicting treatment success
for patients with acute ischemic stroke. The lack of intensity contrast between thrombus and surrounding tissue in CT
images makes manual delineation a difficult and time consuming task. Our aim was to develop an automated method for
thrombus measurement on CT angiography and validate it against manual delineation.
Materials and Methods: Automated thrombus segmentation was achieved using image intensity and a vascular shape prior
derived from the segmentation of the contralateral artery. In 53 patients with acute ischemic stroke due to proximal
intracranial arterial occlusion, automated length and volume measurements were performed. Accuracy was assessed by
comparison with inter-observer variation of manual delineations using intraclass correlation coefficients and Bland–Altman
analyses.
Results: The automated method successfully segmented the thrombus for all 53 patients. The intraclass correlation of
automated and manual length and volume measurements were 0.89 and 0.84. Bland-Altman analyses yielded a bias (limits
of agreement) of 20.4 (28.8, 7.7) mm and 8 (2126, 141) mm3 for length and volume, respectively. This was comparable to
the best interobserver agreement, with an intraclass correlation coefficients of 0.90 and 0.85 and a bias (limits of agreement)
of 20.1 (211.2, 10.9) mm and 217 (2216, 185) mm3.
Conclusions: The method facilitates automated thrombus segmentation for accurate length and volume measurements, is
relatively fast and requires minimal user input, while being insensitive to high hematocrit levels and vascular calcifications.
Furthermore, it has the potential to assess thrombus characteristics of low-density thrombi.
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Introduction
Treatment of acute ischemic stroke aims to reopen the cerebral
arteries and restore cerebral perfusion. Numerous studies have
related image characteristics of thrombus (size, location, and
density) measured on CT, with treatment success [1–5]. Although
in various studies, positive associations have been reported, their
predictive value for treatment success is still under debate. The
methods that were used to assess thrombus characteristics vary
widely. Therefore, thrombus characteristics and outcome reported
in different studies cannot be compared. An automated, objective,
and reliable measurement tool would be of great value in
investigating the association between thrombus characteristics
and treatment outcome, and in facilitating an objective compar-
ison tool between studies.
The composition of thrombus may vary. White clots consist of
platelets and fibrin, whereas red clots are erythrocyte-rich [6].
Clots dominantly composed of red blood cells can be detected on
non-contrast CT (NCCT), where it is expressed as a hyperdense
artery sign. Using an automated method, Riedel & al [7] measured
hyperdense middle cerebral artery thrombus length on NCCT
with mean deviations from the reference values and limits of
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agreement of 0.1 mm60.7 mm using ,2.5 mm slice images,
demonstrating that hyperdense thrombi can be measured accu-
rately. The reported prevalence of hyperdense thrombi in patients
with ischemic stroke ranges from 2% to 58% depending on
thrombus location [8–10]. A challenge for hyperdense thrombus
segmentation techniques on NCCT data is the possible presence of
hyperdensities in intracranial vessels due to calcified arterial walls
or high hematocrit [11] that mimics hyperdense thrombus.
Because of the lack of contrast between low-density thrombi and
surrounding tissue on NCCT, low-density thrombi can only be
visualized and quantified in CTA images using the absence of
contrast-enhanced lumen. However, this approach requires
sufficient retrograde filling of the occluded vessel via collateral
arteries, which occurs in 51% to 87% of the cases [5,12] and is
related to the scan protocol [13]. The Clot Burden Score has been
proposed as an alternative approach for the assessment of
thrombus extent. It is a semi-quantitative measurement that
assesses the volume and location of the thrombus on CTA [1].
However, the Clot Burden Score is a rather crude measure since it
does not include the actual length and volume of the thrombus,
which may be predictors of treatment outcome.
Our aim was to develop and validate an automated method to
detect and quantify thrombus on CTA, requiring minimal user
input. The method exploits the absence of contrast at the site of
thrombus by using anatomical information from the contralateral
arteries. The method was validated for high density thrombus by
comparison with manual delineation of thrombus visible on
NCCT.
Materials and Methods
Patients
We retrospectively collected baseline thin slice (,2.5 mm)
NCCT and CTA image data from the Dutch multi-center image
database of the MR CLEAN clinical trial (Registries: NTR1804/
ISRCTN10888758; protocol available at www.mrclean-trial.org).
CTA was used for the automated thrombus segmentation method.
Thin slice NCCT was used in this study for the manual delineation
of thrombus to validate the automated method. Therefore both
baseline thin slice NCCT and CTA was required for a patient to
be included. All patients had a clinical diagnosis of acute ischemic
stroke due to proximal intracranial arterial occlusion with a deficit
on NIHSS of 2 points or more; occlusion of the distal internal,
middle, or anterior cerebral arteries, the possibility to start
treatment within 6 hours from onset, and age 18 or over.
Exclusion criteria for this study were low quality scans, and
incomplete volume of interest.
Ethic statement
This retrospective study has been approved by the Medical and
Ethical Review Committee (Medisch Ethische Toetsings Com-
missie; http://www.erasmusmc.nl/commissies/metc/) from Eras-
mus MC, Rotterdam, The Netherlands. Moreover, all participat-
ing centers providing image data received approval from their
local medical ethical committee. All patient records, informations
and images were anonymized and de-identified prior to analysis.
All patients or legal representatives signed informed consent.
Automated Thrombus Segmentation Method
The proposed automated thrombus segmentation consists of
three steps: (1) segmentation of the contralateral vasculature; (2)
creation of a mask in the occluded arterial segment by mapping
the contralateral segmentation using mirror symmetry; (3)
segmentation of the thrombus using intensity based region
growing. The image processing pipeline was implemented in
MeVisLab [14] (www.mevislab.de), the different steps are visual-
ized in Figure 1 and the main parameters used are presented in the
Table 1.
The contralateral vasculature was segmented in two steps. First,
proximal and distal seed points were placed manually ensuring
that they covered the contralateral thrombus. Next, a curve was
created through the contralateral vasculature using an optimal
path calculation on a cost image generated with a vesselness filter
[15,16]. Using this curve as an initial estimation of the centerline,
cross-sectional lumen boundary contours were obtained using a
graph-cut technique with kernel regression [17]. A refined
centerline was generated by connecting all centers of mass of the
lumen boundary contours. Subsequently, the vessel radius along
Figure 1. Illustration of the pipeline of the automated method.
(A) The segmentation of the contralateral vasculature is started after
manual seeds point placement. The lumen is segmented using a graph
cut segmentation.(B) The thrombus is detected by mirroring the
centerline and a Bspline registration followed by the segmentation of
the occluded segment. Distal and proximal thrombus position is
detected using the lumen radii.(C) Thrombus is segmented using
tubular masking and region growing.
doi:10.1371/journal.pone.0101985.g001
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the centerline was defined as the average distance from each
center of mass to their respective lumen boundary contour. To
correct for large variations in radii along the center line, which
may be the result of blooming artifacts caused by calcifications, the
radius along the centerline was smoothed with a weighted
Gaussian kernel [18].
An initial estimate of the centerline of the occluded arterial
segment was obtained by mirroring the contralateral centerline.
This estimation was improved by performing a 3D-Bspline
registration using Elastix [19] (www.elastix.isi.uu.nl), of the
mirrored region of interest of the contralateral side with the
region of interest of the occluded arterial segment. The mirrored
centerline was used as an initialization for graph-cut segmentation
with kernel regression. As it was done for the contralateral
vasculature, the lumen radii along the centerline were estimated.
Because the intensity of thrombi (,80 Hounsfield unit) was much
lower than contrast enhanced lumen (,150 to 300 Hounsfield
unit), this segmentation never includes the thrombus. As a result,
the estimated lumen radius at the position of the thrombus was
much smaller than the radius at the contralateral artery. The start
and end positions where the estimated radius was smaller than
0.05 times the radius of the contralateral site were used as an initial
estimation of the proximal and distal location of the occlusion. In
some cases, due to expected insufficient contrast flow from
collaterals, the method used the end part of the vasculature as
distal reference for the masking step.
In the next step the thrombus was segmented. First, a mask was
generated to exclude the surrounding tissues and the contrast
enhanced lumen that should not be considered in the intensity
based region growing segmentation. The mask was defined as a
tube around the centerline of the occluded arterial segment with
the radius of the contralateral arterial segment. The mask ranges
from the estimated proximal and distal location of the occlusion.
Intensity based region growing for thrombus segmentation was
initialized at the centerline approximately 0.5 mm distal to the
estimated proximal location of the occlusion. The region growing
method requires two thresholds. The maximum threshold was
defined as the average intensity along the contralateral centerline
subtracted with the standard deviation of the intensity values along
the same centerline. The minimum threshold was defined as the
minimal intensity along the occluded arterial centerline in the
estimated thrombus added with the standard deviation of the
intensity values. A mathematical morphological opening was
performed to smooth the contours of the thrombus. Length and
volume are automatically measured from the resulting segmenta-
tion. The volume was determined by computing the number of
segmented voxels multiplied by the size of a voxel and the length
was measured from the extremities of the segmented volume along
the centerline.
Manual delineations
Manual delineations of the thrombi were used to assess the
accuracy of the automated method. Three neuroradiologists
(CBM, WHvZ and AvdL), each with more than 10 years of
experience, performed the manual delineations. The observers
only had access to baseline NCCT and CTA images of the patient
during thrombus delineation and were blinded from all clinical
information apart from the symptom side. To assist manual
delineation, a custom made tool was developed in MeVisLab.
With this tool, a manual centerline was first obtained by
interpolating a polynomial curve through manually placed points
in the thrombus on the baseline NCCT scan. Next, the thrombus
contours were delineated on a stretched-vessel view through the
occluded arterial segment. Thrombus volume and length were
subsequently determined from these contours. The different steps
of the manual delineation pipeline are visualized in Figure 2.
Because low-density thrombi were not visible on the NCCT image
data, only high-density thrombi were selected for validation. The
Table 1. Image segmentation parameters and their corresponding values.
Parameters Values (unit)
Vesselness filter (slow, sup) 1.0, 3.5
Graph cut (sinside, soutside) 20, 20 (Hounsfield unit)
Radial Reg. (fractionoutside, Poutside, blursdistance) 0.75, 0.5, 2 (mm)
Weighed Gaussian Reg. (Iteration, sradius) 2, 0.5 (mm)
3D-BSpline registration (Grid spacing, grey level) 2 (mm), 32 (bit)
Mathematical morphology (opening, dilatation (3D kernel (2n+1))) n = 1(voxel), n = 1(voxel)
doi:10.1371/journal.pone.0101985.t001
Figure 2. Illustration of the manual segmentation process. A
centerline is drawn in orthogonal views and subsequently corrected
using MPR viewing. The contours of the thrombus are drawn first in a
longitudinal view and subsequently corrected using on a transversal
view.
doi:10.1371/journal.pone.0101985.g002
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time needed for automated segmentation and manual delineation
was recorded.
Statistical analysis
To assess the accuracy, automated length and volume
measurements were compared with the manual delineations
performed by observer 1. Because of the lack of a reference
standard, we compared variation between the automated method
and observer 1 with the interobserver variation of the manual
delineation. To assess the interobserver agreement, 20 datasets
were delineated by both observer 1 and 2, and 20 other datasets
were delineated by both observer 1 and 3. SPSS (SPSS version
20.0) was used to calculate the intraclass correlation coefficient
(ICC) and to perform a Bland & Altman analyses.
Results
We included 78 consecutive patients with thin slice CTA and
NCCT. In two patients the NCCT and/or CTA scans were
incomplete. Fifty-seven (77%) of the remaining 74 patients had a
visible hyperdense thrombus on NCCT. Four patients were
randomly included in the training set, the remaining 53
constituted the test set. Forty-one percent of the patients were
female and the mean age was 63.4 (611.8) years. The method
successfully segmented the thrombus for all patients. Figure 3
shows a scatter plot of thrombus length and volume measurements
of observer1 versus observers 2, 3, and the automated method.
Table 2 shows the results of the statistical analysis of the volume
and length measurements. There was a high agreement between
observer1 and the automated method with ICC of 0.89 and 0.84
for length and volume respectively. These values were similar to
the agreement between observer 1 and 2 with ICC of 0.90 and
0.85 respectively and exceeded the agreement between observer 1
and 3. For brevity, we omitted the comparison of the automated
method with observer 2 and 3, which were somewhat lower but
comparable to the agreement with observer 1. Figure 4 shows the
results of the Bland-Altman analysis, the agreement between
Figure 3. Scatter plot of thrombus length and volume of observer 1 and automated method (A, B). Scatter plot of thrombus length and
volume of observer1 and observer 2 and 3 (C, D). The solid line represents the identity line.
doi:10.1371/journal.pone.0101985.g003
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observer 1 and the automated method was similar to the
interobserver agreement. This figure also shows that there are
couples of strong outliers in the comparison of observer 1 and 3.
The automated segmentation required 5–7 minutes, while the
manual delineations took in average 20 minutes per patient.
Discussion
In this study, a method for automated thrombus segmentation
on CTA using information from the contralateral arterial segment
was proposed. The method is relatively fast and requires minimal
user input. The validation showed a high accuracy in automated
length and volume measurement, comparable with the best
interobserver agreement.
Current methods to measure thrombus characteristics are either
based on manual or semi-automated measurement of hyperdense
thrombus on non-contrast CT or on quantification of absence of
contrast-enhanced lumen in CT angiography.
Most of these methods are based on direct measurement using a
straightforward ruler tool available on a diagnostic workstation or
visual scoring. More advanced length measurements have been
performed on hyperdense middle cerebral thrombus on NCCT
[6]. The interobserver agreement found in our study is somewhat
smaller than the values reported in a previous study with a mean
deviation from the reference values and limits of agreement of
0.1 mm 60.7 mm for length [7]. This may be explained by the
smaller thrombi that were present in their patient population; all
thrombi were smaller than ,20.0 mm and ,150 mm3. In
contrast to their approach, our method does not rely on intensities
of high-density thrombus and therefore is suitable for segmenta-
tion and measurement of hypodense thrombus. However, we
could not validate the accuracy of automated measurement of low
density thrombus owing to the difficulty of manual segmentation.
Fifty seven (77%) patients had a visible thrombus on NCCT. This
finding is rather high compared to the literature, which suggests
that high-density thrombi are more often observed in thin slice
reconstructions [20].
This study has some limitations. Because the trial was still
ongoing, for many patients not all image data was available in the
image database at the time of this study. Only for 74 out of 230
patients, thin slice (,=2.5 mm) NCCT and CTA data were
available. As a result, further studies on larger cohorts are
necessary to confirm our results in other populations. Moreover,
this study does not determine predictive value of the different
parameters of the thrombus (length, volume or density) as the
patient outcome was not available at the current stage of the trial.
The accuracy of the method could be limited by the large variety
of scanner manufacturers in this study. As a result, imaging
parameters such as reconstruction parameters and slice thickness
varied considerably. However, since our method successfully
segmented the thrombi for all used scans, it appears to be robust to
these variations. Additionally, in our population we did not
observe large variations in the protocols.
Another limitation is the lack of a gold standard for the
thrombus characteristics. Theoretically, measurements of the
surgically removed thrombus could serve as gold standard.
However endovascular techniques disrupt the integrity of the
thrombus. Therefore, we used the current reference standard
(manual delineation) for assessing the accuracy of the automated
method. This comparison indicated that the difference between
the method and the manual delineation is within the range of
interobserver disagreement. Because of the large effort required
for manual assessment, the number of measurements of observer 2
and 3 was rather limited.
Because manual segmentation of low-density thrombus on
NCCT was difficult even for very experienced neuroradiologists,
accuracy of automated measurement could not be validated for
these thrombi. For segmentation of low density thrombi, good
collateral retrograde filling may be required. Current literature
suggests that good collateral retrograde filling of an occluded
artery is common but not always the case [5,12]. Poor retrograde
filling may result in overestimation of the thrombus on CTA.
However, due to the intensity based region growing segmentation
used in our pipeline, our method is not sensitive for poor
Table 2. Comparison of volume and length measurements for the automated method and observers.
Average ± SD (min, max) N
Average paired
difference ± SD
Limits of agreement,
upper/lower limit ICC
Length (mm)
Observer 1 15.169.0 (2.0, 43.8) 53 20.464.3 28.8/7.7 0.89*
Automated 15.469.3 (2.7, 42.8)
Observer 1 15.969.0 (3.0, 36.9) 20 20.165.7 211.2/10.9 0.90*
Observer 2 16.169.8 (2.0, 36.9)
Observer 1 17.1610.0 (6.0, 43.8) 20 25.0615.1 234.7/24.6 0.31
Observer 3 22.1613.9 (4.0, 57.9)
Volume (mm3)
Observer 1 1526125 (12, 542) 53 7.5667 2126/141 0.84*
Automated 1456110 (11, 406)
1Observer 1 1376122 (13, 460) 20 2176103 2218/185 0.85*
Observer 2 1546163 (12, 656)
Observer 1 2056127 (15, 542) 20 2256127 2340/224 0.61{
Observer 3 2306157 (68, 644)
*p-value ,0.001
{p-value ,0.005.
doi:10.1371/journal.pone.0101985.t002
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retrograde filling. Actually the large agreement between the
automated method using CTA and the manual delineation on
NCCT indicates that the method indeed is robust for delayed
retrograde filling. In future studies, low-density thrombus
segmentation could be validated by comparison with other
measurements such as clot-burden score.
In our method, we assumed symmetry in order to retrieve the
radius of the occluded segment for background masking. However,
the occluded vascular tree and the contralateral vascular tree are
not perfectly symmetric. To deal with this asymmetry, we used an
elastic, non-rigid registration, which allows for differences in
length, shape, and location of bifurcation. Because the accuracy of
the method in 53 cases is in the range of the interobserver
variability, we believe that the non-rigid registration accurately
corrects for these contralateral differences. Yet, little is known
about the degree of symmetry of radii of the proximal intracranial
arteries. Violation of this assumption may result in errors. This
could explain the larger limit of agreement for volume measure-
ments compared to length measurement.
In three cases, we observed a strong disagreement between
observer 1 and observer 3. Retrospective analysis of these three
outliers revealed that this could be explained by high hematocrit
level and vascular calcifications. Arteries in image datasets of
patients with elevated hematocrit are known to mimic high density
Figure 4. Bland-Altman plot comparing thrombus volume and length as measured by observer 1 and the automated method (A, B),
and for all observers (D, C).
doi:10.1371/journal.pone.0101985.g004
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thrombi in CT images because of the higher attenuation on CT
[20]. It is not uncommon to exclude patients with high hematocrit
in thrombus analysis [4]. We believe that the observers disagreed
on the interpretation of these hyperdense arteries. By excluding
patients with high-hematocrit levels, as was done in previous
studies, the interobserver agreement significantly improved to ICC
of 0.85 and 0.78 for length and volume respectively. These values
are in the range of the ICC of observer 1 and observer 2.
Image-supported treatment decision for patients with acute
ischemic stroke was recently, recommended before treatment
initialization by the American Society of Neuroradiology as well as
number of current studies aim to it [4,12,21,22]. Predictors of
successful recanalization are likely to differ for mechanical
thrombectomy and intra-arterial fibrinolysis. Thrombus charac-
teristics have been suggested to be a determinant for inclusion for
IV treatment. Indeed, the thrombus length might particularly be
useful as a parameter to better identify patients who are unlikely to
benefit from IVT [21]. In an ongoing randomized controlled trial,
it is currently uses as an inclusion criterion [http://clinicaltrials.
gov/show/NCT01429350]. Whereas thrombus burden was an
important predictor for the success of IV treatment, mechanical
thrombectomy may be more influenced by other target charac-
teristics like thrombus branching and vessel curvature [23].
The presented method has the potential to support current
clinical research and to be introduced in clinical practice to
support treatment decisions for patients with acute ischemic stroke.
With this method, multivariate analysis of many thrombus
characteristics (length, volume, density, curvature, etc.) could be
performed to relate these to stroke subtype, response to treatment,
and patient outcome measures. This way, thrombus characteristics
with the most prognostic value could be determined. However,
further prospective studies will have to demonstrate the feasibility
of this method in acute clinical setting and determine the
predictive value of imaging features of thrombus on CTA.
Conclusions
We developed and validated an automated tool performing
thrombus length and volume measurements. We have shown that
for high-density thrombi, this method is highly accurate, with
accuracies comparable to interobserver agreements. Furthermore,
this method was shown to be able to segment thrombi even for
cases with high hematocrit level or calcifications, and thus could
facilitate segmentation of hypodense thrombi. However, further
studies on larger cohorts are necessary to confirm our results in
larger and different populations.
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